SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL Inc. is experiencing a sharp sell-off, down significantly after an NHS trial for its Galleri multi-cancer early detection test reportedly missed a primary endpoint; however, community discussion emphasizes this as an overreaction, pointing to strong Q4 revenue and EPS beats, a solid cash runway, and the test's proven ability to detect early-stage cancers, fueling calls to buy the dip and anticipate a potential short squeeze.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed following recent announcements of a $100 million public stock offering alongside a separate $100 million non-dilutive royalty financing deal, generating a split community reaction between concerns over dilution and recognition of strategic backing from a specialized biotech investor. Further interest surrounds the company's upcoming data presentation on its glioblastoma program at a key industry summit, with investors also awaiting anticipated updates for its broader oncology pipeline.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending amidst investor anticipation for its conference and financial results, fueled by strong underlying sales growth from its products and the Alani Nu integration. Nevertheless, community sentiment is sharply divided, with ongoing discussions scrutinizing management's communication and the implications of Pepsi's deepening strategic involvement, including persistent buyout speculation.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending on the heels of robust 2025 revenue, a significant patent extension for its key drugs until 2042, and the launch of a Phase 3 trial for IBSRELA in Chronic Idiopathic Constipation. The community is actively discussing these catalysts alongside heightened speculation regarding a potential acquisition and multiple analyst price target increases, despite some frustration over perceived stock manipulation.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending due to its Q4 earnings report, which highlighted robust revenue growth, especially in the US, but also a net loss driven by increased credit loss provisions; this has sparked a heated community debate over whether the stock's substantial decline is an overreaction or signals fundamental issues within the buy now, pay later sector.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp. is actively discussed after exceeding Q4 earnings and revenue expectations, fueled by strong financial performance and record free cash flow. However, a cautious 2026 production outlook is creating community debate, with many questioning the stock's current valuation given the continued strength in gold prices.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is actively discussed as a major offshore drilling powerhouse following its all-stock acquisition of Valaris, a deal expected to create significant synergies and enhance its contract backlog. Community sentiment is largely bullish, anticipating strong earnings and potential for a short squeeze, driven by increasing demand and day rates in the energy sector.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care Inc

Tandem Diabetes Care is trending due to recent strategic partnerships with Abbott and Eli Lilly for integrated diabetes solutions and new Control-IQ+ technology, which are creating bullish sentiment amidst a volatile period marked by a voluntary medical device correction and mixed financial guidance. The community is sharply divided between those anticipating a major rebound and potential acquisition, and others fearing continued competitive and operational challenges in the diabetes market.

Sprouts Farmers Market, Inc. engages in the operation of healthy grocery stores. The firm specializes in fresh, natural and organic products. Its products include fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items. The company was founded by Stan Boney, Shon Alexander Boney, and Kevin K. Easler on July 11, 2002 and is headquartered in Phoenix, AZ.

Sprouts Farmers Market Inc

Sprouts Farmers Market is trending as its recent strong earnings, new store expansion, and ongoing share buyback program spark investor interest. However, community debate persists over the stock's substantial decline from prior highs and concerns about in-store pricing and consumer demand.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamai Technologies is trending following a mixed earnings report, where strong Q4 performance and growth in security and cloud solutions were eclipsed by lower-than-expected forward guidance, fueling community debate on its AI edge computing pivot amidst a competitive landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 Soft Drinks Stocks Set to Gain as Innovation Offsets Cost Pressures

Health-focused innovation and digital growth lift soft drink makers, even as rising input costs and tariff uncertainty pressure margins. Can KO, PEP, MNST, KDP and COCO stay ahead?

Monster Beverage (MNST) Earnings Expected to Grow: Should You Buy?

Monster Beverage (MNST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cumberland Partners Ltd Increases Stock Position in Monster Beverage Corporation $MNST

Cumberland Partners Ltd raised its position in Monster Beverage Corporation (NASDAQ:MNST - Free Report) by 289.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The...

PNC Financial Services Group Inc. Increases Holdings in Monster Beverage Corporation $MNST

PNC Financial Services Group Inc. increased its holdings in shares of Monster Beverage Corporation (NASDAQ:MNST - Free Report) by 6.3% in the 3rd quarter, according to its most recent Form 13F filing...

Monster Beverage (MNST) Expected to Announce Quarterly Earnings on Thursday

Monster Beverage (NASDAQ:MNST) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Monster Beverage (NASDAQ:MNST) Hits New 12-Month High - Should You Buy?

Monster Beverage (NASDAQ:MNST) Sets New 12-Month High - Still a Buy...

Monster Beverage Gears Up for Q4 Earnings: Here's What You Should Know

MNST eyes a strong Q4 as global energy drink demand, new flavors and pricing moves aim to boost growth and margins.

Boston Beer's Q4 Results: Is an Earnings Surprise in the Cards?

SAM's Q4 performance is likely to reflect seasonal weakness, softer volumes and hard seltzer declines as inventory cuts and macro headwinds squeeze margins.

FEMSA Q4 Earnings on The Horizon: Will It Surprise Investors?

FMX gears up for Q4 with revenues seen soaring 24.6% and EPS at $1.53, but margin pressures and cost headwinds may temper gains.

Keurig Dr Pepper Q4 Earnings Approaching: Will It Surprise Investors?

KDP eyes Q4 growth with revenues seen up 7.2% to $4.36B, but coffee weakness and inflation may test margins with Refreshment up 12.5% and EPS at 59 cents.

Monster Beverage Corp. is a holding company, which engages in the development, marketing, sale, and distribution of energy drink beverages and concentrates. It operates through the following segments: Monster Energy Drinks, Strategic Brands, and Other. The Monster Energy Drinks segment sells ready-to-drink packaged energy drinks to bottlers and full-service beverage distributors. The Strategic Brands segment sells concentrates and beverage bases to authorized bottling and canning operations. The Other segment consists of certain products sold by its subsidiary, American Fruits and Flavors LLC to independent third-party customers. The company was founded on April 25, 1990, and is headquartered in Corona, CA.

MNST
Monster Beverage Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNST News

MNSTMonster Beverage Corp.